Olbas Inhaler nasal stick

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

Levomenthol; Cajuput Oil ; Eucalyptus Oil; Peppermint oil

Available from:

GR Lane Health Products Ltd

ATC code:

R01AX

INN (International Name):

Levomenthol; Cajuput Oil ; Eucalyptus Oil; Peppermint oil

Dosage:

. percent volume/volume

Pharmaceutical form:

Nasal stick

Prescription type:

Product not subject to medical prescription

Therapeutic area:

Other nasal preparations

Authorization status:

Marketed

Authorization date:

1997-09-05

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Olbas Inhaler nasal stick
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Nasal stick.
White tube closed with a white cap and containing a wad dosed with
Olbas Inhaler oil.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
For the symptomatic relief of blocked up sinuses, catarrh, hay fever,
colds and influenza.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Insert into each nostril in turn and inhale whilst keeping the other
nostril closed. May be used up to four times per hour
as required.
4.3 CONTRAINDICATIONS
Hypersensitivity to the active substances.
Use in infants and young children.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
If symptoms persist, seek medical advice. Keep out of the sight and
reach of children. Store below 25
°
C.
4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
No interaction studies have been performed.
Cajuput Oil
20% w/w
Eucalyptus Oil
20% w/w
Levomenthol
40% w/w
Peppermint Oil
20% w/w
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_3_
_/_
_0_
_8_
_/_
_2_
_0_
_1_
_2_
_C_
_R_
_N_
_ _
_2_
_0_
_5_
_6_
_1_
_9_
_6_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.6 FERTILITY, PREGNANCY AND LACTATION
There are no reports of adverse effects when used during pregnancy and
lactation and hence the product may be used.
4.7 EFFECTS ON ABILITY TO DRIVE AND USE MACHINES
Not relevant.
4.8 UNDESIRABLE EFFECTS
Contact dermatitis